Tarık Kırkgöz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tarık Kırkgöz has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Behzat Özkan
Department of Pediatric Endocrinology, University of Health Sciences, İzmir Faculty of Medicine, Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, İzmir, Turkey
10 shared publications - Özlem Nalbantoğlu
Department of Pediatric Endocrinology, University of Health Sciences, İzmir Faculty of Medicine, Dr. Behçet Uz Children’s Hospital, İzmir, Türkiye
7 shared publications - Serap Turan
Marmara University School of Medicine Department of Pediatric Endocrinology, Istanbul, Turkey
5 shared publications - Serkan Bilge Koca
Department of Pediatrics, Division of Endocrinology, University of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye
5 shared publications - Sezer Acar
Division of Pediatric Endocrinology, Dr. Behçet Uz Children’s Education and Research Hospital, Izmir, Turkey
5 shared publications - Filiz Hazan
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. BEHÇET UZ HEALTH RESEARCH CENTER FOR PEDIATRIC DISEASES AND SURGERY
4 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Springer Nature in BMC Pediatrics
Pancreatic steatosis is associated with exocrine pancreatic dysfunction in children with MASLD: a prospective cross-sectional study
- 26 August 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessPancreatic steatosis is associated with exocrine pancreatic dysfunction in children with MASLD: a prospective cross-sectional study
- 24 August 2026
- Published by Elsevier in Archives de Pédiatrie
- Vol. 33 (7)
Clinical and molecular characterization of 5α-reductase deficiency type 2: First report of a family with homozygous deletion in exon 1 of SRD5A2
- 24 August 2026
- Published by Elsevier in Archives de Pédiatrie
- Vol. 33 (7)
Clinical and molecular characterization of 5α-reductase deficiency type 2: First report of a family with homozygous deletion in exon 1 of SRD5A2
- 2 July 2026
- Published by S. Karger AG in Hormone Research in Paediatrics
- p. 1-31
Circulating mRNA and miRNA signatures used as predictive markers of lifestyle modification outcomes in pediatric obesity management
The response to lifestyle modification (LSM) in children with obesity is variable and difficult to predict. Aim: A systematic search for molecular markers to predict outcomes of LSM in pediatric obesity management. Patients and Methods: Out of 240 children with obesity (BMI>97%) recruited to a prospective ‘multi-OMICS’ study granted by ESPE Research Unit, 159 subjects (age 8-17 yrs, median 12.8 yrs; 45% females) finished twelve-months (between visits V0-V12) of LSM at three clinical centers (Poland, Turkey, Italy). Four of >180 baseline (V0, before LSM) clinical and laboratory features (sex, age, severity of obesity at V0, steroid metabolome) were used to select 50 representatives for RNA-seq analysis. We searched for circulating mRNA & miRNA capable of establishing the link with positive response to LSM defined by a decrease in z-score BMI (delta z-score BMI V12-V0<0, Responders/RS). First, the candidate gene approach with previously documented STAT3, CORO1C, SERPINH1, MVP, ITGB5 (upregulated in obesity), PCM1, SIRT1, EEF1G, PTEN and RPS2 (down-regulated in obesity) hub genes was applied. The pairwise ratios of transcripts per million (TPM)s of these genes were tested for statistical significance between RS (n=31) and non-RS (n=19) groups. Secondly, the TPM expression values of 2,129 miRNAs and 33,246 RPL13A-normalized mRNAs were compared between RS and non-RS to get a list of putative significant genes (p<0.05; the Welch t-test). Enrichr, a web-based tool (http://amp.pharm.mssm.edu/Enrichr), was used for analysing gene sets. Results: Expression values for 909 mRNA and 24 miRNA genes were significantly different between RS vs non-RS. For example, STAT3/PTEN, CORO1C/PTEN, MVP/PTEN; miRNA-10a, miRNA-122, miRNA-127, miRNA-502, miRNA-210 were significantly higher and SIRT1/PTEN, EEF1G/PTEN, RPS2/PTEN, miRNA-27a were lower comparing RS vs. non-RS (p= 0.009, 0.022, 0.030, 0.048, 0.029, 0.045, 0.035, 0.020, 0.047, 0.04, 0.039, 0.029, respectively). Several pathways, including “Vitamin B6 metabolism" and “Insulin receptor signaling”, were enriched in our differentially expressed mRNA (p<0.001): PNPO, PHOSPHO2, PDXP, PSAT1 were up-regulated in RS vs. non-RS. “Leptin signaling pathway WP2034” were enriched in STAT3 and PTEN (p<0.0001). Conclusions: The role of the balance between STAT3 and PTEN in LSM was discovered. The importance of previously described miRNA markers (miRNA-122, miRNA-127, miRNA-27a) related to adipogenesis risk, insulin resistance, hepatic fat reduction, PPAR-γ expression were confirmed. A combination of the previously reported V0 Leptin feature together with STAT3/PTEN and miRNA-27a levels showed promising predictive results. Our findings not only showed the predictive molecular markers but also pointed to their role in personalization of therapeutic management.
- 2 July 2026
- Published by S. Karger AG in Hormone Research in Paediatrics
- p. 1-31
Circulating mRNA and miRNA signatures used as predictive markers of lifestyle modification outcomes in pediatric obesity management
The response to lifestyle modification (LSM) in children with obesity is variable and difficult to predict. Aim: A systematic search for molecular markers to predict outcomes of LSM in pediatric obesity management. Patients and Methods: Out of 240 children with obesity (BMI>97%) recruited to a prospective ‘multi-OMICS’ study granted by ESPE Research Unit, 159 subjects (age 8-17 yrs, median 12.8 yrs; 45% females) finished twelve-months (between visits V0-V12) of LSM at three clinical centers (Poland, Turkey, Italy). Four of >180 baseline (V0, before LSM) clinical and laboratory features (sex, age, severity of obesity at V0, steroid metabolome) were used to select 50 representatives for RNA-seq analysis. We searched for circulating mRNA & miRNA capable of establishing the link with positive response to LSM defined by a decrease in z-score BMI (delta z-score BMI V12-V0<0, Responders/RS). First, the candidate gene approach with previously documented STAT3, CORO1C, SERPINH1, MVP, ITGB5 (upregulated in obesity), PCM1, SIRT1, EEF1G, PTEN and RPS2 (down-regulated in obesity) hub genes was applied. The pairwise ratios of transcripts per million (TPM)s of these genes were tested for statistical significance between RS (n=31) and non-RS (n=19) groups. Secondly, the TPM expression values of 2,129 miRNAs and 33,246 RPL13A-normalized mRNAs were compared between RS and non-RS to get a list of putative significant genes (p<0.05; the Welch t-test). Enrichr, a web-based tool (http://amp.pharm.mssm.edu/Enrichr), was used for analysing gene sets. Results: Expression values for 909 mRNA and 24 miRNA genes were significantly different between RS vs non-RS. For example, STAT3/PTEN, CORO1C/PTEN, MVP/PTEN; miRNA-10a, miRNA-122, miRNA-127, miRNA-502, miRNA-210 were significantly higher and SIRT1/PTEN, EEF1G/PTEN, RPS2/PTEN, miRNA-27a were lower comparing RS vs. non-RS (p= 0.009, 0.022, 0.030, 0.048, 0.029, 0.045, 0.035, 0.020, 0.047, 0.04, 0.039, 0.029, respectively). Several pathways, including “Vitamin B6 metabolism" and “Insulin receptor signaling”, were enriched in our differentially expressed mRNA (p<0.001): PNPO, PHOSPHO2, PDXP, PSAT1 were up-regulated in RS vs. non-RS. “Leptin signaling pathway WP2034” were enriched in STAT3 and PTEN (p<0.0001). Conclusions: The role of the balance between STAT3 and PTEN in LSM was discovered. The importance of previously described miRNA markers (miRNA-122, miRNA-127, miRNA-27a) related to adipogenesis risk, insulin resistance, hepatic fat reduction, PPAR-γ expression were confirmed. A combination of the previously reported V0 Leptin feature together with STAT3/PTEN and miRNA-27a levels showed promising predictive results. Our findings not only showed the predictive molecular markers but also pointed to their role in personalization of therapeutic management.
- Open Access
- 11 April 2026
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
The role of Spexin and Phoenixin-20 in girls during puberty
Spexin has an inhibitory effect on the hypothalamus (GnRH expression), pituitary (LH and FSH expression) and ovary (estradiol expression). However, Phoenix
- 11 April 2026
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Open AccessThe role of Spexin and Phoenixin-20 in girls during puberty
Spexin has an inhibitory effect on the hypothalamus (GnRH expression), pituitary (LH and FSH expression) and ovary (estradiol expression). However, Phoenix
- Open Access
- 4 February 2026
- Published by Pediatric Practice and Research Journal in Pediatric Practice and Research
- Vol. 14 (1) , 1964496
Retrospective Evaluation of the Clinical Characteristics, Laboratory Findings, and Treatment Approaches in Pediatric and Adolescent Patients Diagnosed with Type 2 Diabetes Mellitus: A Single-Center Experience
Background: The prevalence of type 2 diabetes mellitus (T2DM) in children has been increasing in parallel with the rise in obesity. Due to its insidious onset and slow progression, complications often manifest later in adulthood. This study aims to evaluate the clinical and laboratory findings, and complication rates in pediatric patients with T2DM. Methods: We reviewed the medical records of patients diagnosed with T2DM and followed in our clinic between January 2014 and January 2023. Demographic, clinical, laboratory, and treatment data were recorded. Results: Sixty-three patients (42 females) were included in the study. The mean age at diagnosis was 13.9 ± 2.2 years (range 11.1–17.3), 95% were pubertal. The mean weight, height, and body mass index (BMI) standard deviation scores (SDS) were 2.3 ± 1.5 (range -3.2 to 5.9), 0.3 ± 1.2 (range -2.2 to 3.5), and 2.1 ± 1.1 (range -2.5 to 3.9), respectively. Polyuria and polydipsia were reported in 22 patients (34.9%) at diagnosis. Four patients presented with ketoacidosis. A family history of T2DM was present in 34 patients (54%). Antibodies were positive in four patients (6.6%). The mean HbA1c ( glycosylated hemoglobin) level was 8.7% ± 2.0. Treatment included metformin alone in 24 patients (38%), metformin plus insulin in 29 (46%), and insulin alone in five (8.0%). Regarding complications, neuropathy was observed in one patient (1.6%), nephropathy in two patients (3.2%). Conclusions: Prevention strategies on T2DM must focus on reducing obesity from an early age. Community-based interventions promoting healthy eating and physical activity are essential.
- 4 February 2026
- Published by Pediatric Practice and Research Journal in Pediatric Practice and Research
- Vol. 14 (1) , 1964496
Open AccessRetrospective Evaluation of the Clinical Characteristics, Laboratory Findings, and Treatment Approaches in Pediatric and Adolescent Patients Diagnosed with Type 2 Diabetes Mellitus: A Single-Center Experience
Background: The prevalence of type 2 diabetes mellitus (T2DM) in children has been increasing in parallel with the rise in obesity. Due to its insidious onset and slow progression, complications often manifest later in adulthood. This study aims to evaluate the clinical and laboratory findings, and complication rates in pediatric patients with T2DM. Methods: We reviewed the medical records of patients diagnosed with T2DM and followed in our clinic between January 2014 and January 2023. Demographic, clinical, laboratory, and treatment data were recorded. Results: Sixty-three patients (42 females) were included in the study. The mean age at diagnosis was 13.9 ± 2.2 years (range 11.1–17.3), 95% were pubertal. The mean weight, height, and body mass index (BMI) standard deviation scores (SDS) were 2.3 ± 1.5 (range -3.2 to 5.9), 0.3 ± 1.2 (range -2.2 to 3.5), and 2.1 ± 1.1 (range -2.5 to 3.9), respectively. Polyuria and polydipsia were reported in 22 patients (34.9%) at diagnosis. Four patients presented with ketoacidosis. A family history of T2DM was present in 34 patients (54%). Antibodies were positive in four patients (6.6%). The mean HbA1c ( glycosylated hemoglobin) level was 8.7% ± 2.0. Treatment included metformin alone in 24 patients (38%), metformin plus insulin in 29 (46%), and insulin alone in five (8.0%). Regarding complications, neuropathy was observed in one patient (1.6%), nephropathy in two patients (3.2%). Conclusions: Prevention strategies on T2DM must focus on reducing obesity from an early age. Community-based interventions promoting healthy eating and physical activity are essential.
- 2 January 2026
- Published by Taylor & Francis in Endocrine Research
- Vol. 51 (1) , 53-58
Early treatment responses in childhood Graves’ disease: factors affecting the normalization period of thyroid hormones
Herein, we aimed to reveal the factors affecting the early treatment responses and the normalization process of thyroid hormone levels in childhood Graves' disease.. This retrospective study included 46 pediatric patients who were diagnosed with Graves' disease and started treatment during a period of 10 years, and whose at least one of their free T3 (fT3) or free T4 (fT4) levels decreased to the reference range during follow-up. The normalization time of fT3 and fT4 were 5 (3-8) and 3.5 (2-7) weeks after the treatment initiation, respectively. Gender, age, pubertal status, presence of goiter, ophthalmopathy or tachycardia, basal thyroid hormone levels, initial dose of methimazole, and addition of beta-blockers did not show an effect on the normalization time of either fT3 or fT4 (p > 0.05). In those under the age of 12 (n = 15) with a high TRAb titer (>10 IU/L), the time for normalization of fT3 was longer (p = 0.024), and in those with ophthalmopathy, this process was longer for fT4 (p = 0.017). By these results, we showed that early treatment response and the normalization period of thyroid hormones were not related to the initial treatment dose.
- 2 January 2026
- Published by Taylor & Francis in Endocrine Research
- Vol. 51 (1) , 53-58
Early treatment responses in childhood Graves’ disease: factors affecting the normalization period of thyroid hormones
Herein, we aimed to reveal the factors affecting the early treatment responses and the normalization process of thyroid hormone levels in childhood Graves' disease.. This retrospective study included 46 pediatric patients who were diagnosed with Graves' disease and started treatment during a period of 10 years, and whose at least one of their free T3 (fT3) or free T4 (fT4) levels decreased to the reference range during follow-up. The normalization time of fT3 and fT4 were 5 (3-8) and 3.5 (2-7) weeks after the treatment initiation, respectively. Gender, age, pubertal status, presence of goiter, ophthalmopathy or tachycardia, basal thyroid hormone levels, initial dose of methimazole, and addition of beta-blockers did not show an effect on the normalization time of either fT3 or fT4 (p > 0.05). In those under the age of 12 (n = 15) with a high TRAb titer (>10 IU/L), the time for normalization of fT3 was longer (p = 0.024), and in those with ophthalmopathy, this process was longer for fT4 (p = 0.017). By these results, we showed that early treatment response and the normalization period of thyroid hormones were not related to the initial treatment dose.
- 10 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (1) , 21-27
Bioelectrical impedance analysis and hormonal assessment in adolescents with pubertal gynecomastia
Objectives: Gynecomastia is common during adolescence, yet its relationship with body composition remains unclear. This study investigates differences in body composition, fat distribution, and hormonal profiles between adolescents with gynecomastia and healthy controls. Methods: This case–control study included 70 adolescents diagnosed with gynecomastia and 67 healthy controls matched for age and Tanner stage. Anthropometric measurements, bioelectrical impedance analysis (BIA), and serum hormonal profiles were assessed. Body composition parameters, including fat mass (FM), fat-free mass (FFM), muscle mass (MM), bone mass (BM), total body water (TBW), muscle-to-fat mass ratio (MFR), and basal metabolic rate (BMR), were measured using the Tanita MC-780 MA device. Results: Adolescents with gynecomastia exhibited significantly higher trunk fat mass (trunk fat mass: 20.60 ± 9.48 % vs. 17.64 ± 6.61 %, p=0.0462) and hormonal alterations, including reduced follicle-stimulating hormone (FSH) and free thyroxine (fT4) levels (FSH: 2.7 ± 1.4 vs. 3.5 ± 2.0 IU/L, p=0.0164; fT4 12.4 ± 1.9 vs. 13.1 ± 2.5 p=0.0193). Conclusions: These findings highlight the interplay between adiposity and endocrine changes in gynecomastia, warranting further exploration of underlying causative factors.
- 10 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (1) , 21-27
Bioelectrical impedance analysis and hormonal assessment in adolescents with pubertal gynecomastia
Objectives: Gynecomastia is common during adolescence, yet its relationship with body composition remains unclear. This study investigates differences in body composition, fat distribution, and hormonal profiles between adolescents with gynecomastia and healthy controls. Methods: This case–control study included 70 adolescents diagnosed with gynecomastia and 67 healthy controls matched for age and Tanner stage. Anthropometric measurements, bioelectrical impedance analysis (BIA), and serum hormonal profiles were assessed. Body composition parameters, including fat mass (FM), fat-free mass (FFM), muscle mass (MM), bone mass (BM), total body water (TBW), muscle-to-fat mass ratio (MFR), and basal metabolic rate (BMR), were measured using the Tanita MC-780 MA device. Results: Adolescents with gynecomastia exhibited significantly higher trunk fat mass (trunk fat mass: 20.60 ± 9.48 % vs. 17.64 ± 6.61 %, p=0.0462) and hormonal alterations, including reduced follicle-stimulating hormone (FSH) and free thyroxine (fT4) levels (FSH: 2.7 ± 1.4 vs. 3.5 ± 2.0 IU/L, p=0.0164; fT4 12.4 ± 1.9 vs. 13.1 ± 2.5 p=0.0193). Conclusions: These findings highlight the interplay between adiposity and endocrine changes in gynecomastia, warranting further exploration of underlying causative factors.
- 2 April 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 38 (6) , 599-606
The diagnostic utility of bioelectrical impedance analysis in distinguishing precocious puberty from premature thelarche
Objectives: Clinical (assessing breast development), laboratory (FSH, LH, estradiol, and GnRH stimulation test), and radiological methods (bone age and pelvic ultrasonography) are used to distinguish central precocious puberty (CPP) from premature thelarche (PT). We examined also via bioelectrical impedance analysis (BIA). Methods: The fat mass (FM), fat-free mass (FFM), muscle mass (MM), bone mass (BM), total body water, and percentages (%), basal metabolic rate, phase angle (PhA), muscle-to-fat ratio (MFR), sarcopenic index, and segmental body proportions were determined via Tanita MC-780 MA model measuring device. Results: A total of 111 girls, 34 with CPP, 35 with PT, and 42 with healthy controls, were included. Although the baseline weight, height, and BMI SDS of the groups were not statistically different, the FM (%) was found to be lower (p=0.021), and the FFM (%) (p=0.021), MM (%) (p=0.015), BM (%) (p=0.022), and MFR values (p=0.017) were higher in CPP group. In CPP group, right arm FM (%) (p=0.016), left arm FM (%) (p=0.007), and trunk FM (%) (p=0.008) were lower than other groups. Conclusions: We detected a MFR cutoff value of (2.96) with 58.8 % sensitivity and 58.4 % specificity, a cutoff value of (3.57) with 50 % sensitivity and 82 % specificity to differentiate CPP cases from others (PT and healthy controls). These rates are relatively low, but these are the first results in this field and may be guiding for studies conducted in large series.
- 2 April 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 38 (6) , 599-606
The diagnostic utility of bioelectrical impedance analysis in distinguishing precocious puberty from premature thelarche
Objectives: Clinical (assessing breast development), laboratory (FSH, LH, estradiol, and GnRH stimulation test), and radiological methods (bone age and pelvic ultrasonography) are used to distinguish central precocious puberty (CPP) from premature thelarche (PT). We examined also via bioelectrical impedance analysis (BIA). Methods: The fat mass (FM), fat-free mass (FFM), muscle mass (MM), bone mass (BM), total body water, and percentages (%), basal metabolic rate, phase angle (PhA), muscle-to-fat ratio (MFR), sarcopenic index, and segmental body proportions were determined via Tanita MC-780 MA model measuring device. Results: A total of 111 girls, 34 with CPP, 35 with PT, and 42 with healthy controls, were included. Although the baseline weight, height, and BMI SDS of the groups were not statistically different, the FM (%) was found to be lower (p=0.021), and the FFM (%) (p=0.021), MM (%) (p=0.015), BM (%) (p=0.022), and MFR values (p=0.017) were higher in CPP group. In CPP group, right arm FM (%) (p=0.016), left arm FM (%) (p=0.007), and trunk FM (%) (p=0.008) were lower than other groups. Conclusions: We detected a MFR cutoff value of (2.96) with 58.8 % sensitivity and 58.4 % specificity, a cutoff value of (3.57) with 50 % sensitivity and 82 % specificity to differentiate CPP cases from others (PT and healthy controls). These rates are relatively low, but these are the first results in this field and may be guiding for studies conducted in large series.
- 19 December 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (9) , e3021-e3030
Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia
Context: Hereditary hypophosphatemia (HH), is a rare condition related to decreased renal tubular phosphate reabsorption. Although X-linked hypophosphatemia or PHEX gene variant is the most frequent cause of HH, recent advances in next-generation sequencing (NGS) techniques enable the identification of genetic etiologies as a whole. Objective: This work aimed to identify genetic causes of HH using various genetic testing methods and to compare clinical features between FGF23-dependent and FGF23-independent HH groups. Methods: Fifty patients (24 males) from 39 unrelated families were included. Based on initial evaluation, PHEX gene sequencing was performed in patients with clinical and biochemical findings suggestive of FGF23-dependent HH. If sequencing showed no alterations, multiplex ligation-dependent probe amplification (MLPA) analysis for PHEX was conducted. Initially, a specific gene panel was performed for FGF23-independent HH or those in whom the PHEX gene showed no genetic alteration. Results: Genetic etiology was revealed in 43 patients from 33 families. PHEX gene variants (4 novel) were identified in 24 patients from 19 unrelated families (50%). SLC34A3 was the second most common (16.6%) and the rest were rarer causes of hypophosphatemia (DMP1 n = 3, SLC34A1 n = 2, CLCN5 n = 2, OCRL n = 2, FAM20C n = 1, SLC2A2 n = 1). When the genetically proven FGF23-dependent (n = 28) and FGF23-independent (n = 15) HH groups were compared for clinical and biochemical features; lower phosphate and TmP/GFR SDSs and higher ALP SDS with more severe clinical rickets were detected in FGF23-dependent group, whereas higher serum and urine calcium and lower PTH levels were detected in FGF23-independent group. Conclusion: The application of MLPA provided an additional explanatory value of 10% to the molecular etiology. However, 10% of the cases of HH still remain unexplained even after a comprehensive genetic work-up. Biochemical findings suggest distinct biochemical profiles between FGF23-dependent and FGF23-independent HH groups.
- 19 December 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (9) , e3021-e3030
Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia
Context: Hereditary hypophosphatemia (HH), is a rare condition related to decreased renal tubular phosphate reabsorption. Although X-linked hypophosphatemia or PHEX gene variant is the most frequent cause of HH, recent advances in next-generation sequencing (NGS) techniques enable the identification of genetic etiologies as a whole. Objective: This work aimed to identify genetic causes of HH using various genetic testing methods and to compare clinical features between FGF23-dependent and FGF23-independent HH groups. Methods: Fifty patients (24 males) from 39 unrelated families were included. Based on initial evaluation, PHEX gene sequencing was performed in patients with clinical and biochemical findings suggestive of FGF23-dependent HH. If sequencing showed no alterations, multiplex ligation-dependent probe amplification (MLPA) analysis for PHEX was conducted. Initially, a specific gene panel was performed for FGF23-independent HH or those in whom the PHEX gene showed no genetic alteration. Results: Genetic etiology was revealed in 43 patients from 33 families. PHEX gene variants (4 novel) were identified in 24 patients from 19 unrelated families (50%). SLC34A3 was the second most common (16.6%) and the rest were rarer causes of hypophosphatemia (DMP1 n = 3, SLC34A1 n = 2, CLCN5 n = 2, OCRL n = 2, FAM20C n = 1, SLC2A2 n = 1). When the genetically proven FGF23-dependent (n = 28) and FGF23-independent (n = 15) HH groups were compared for clinical and biochemical features; lower phosphate and TmP/GFR SDSs and higher ALP SDS with more severe clinical rickets were detected in FGF23-dependent group, whereas higher serum and urine calcium and lower PTH levels were detected in FGF23-independent group. Conclusion: The application of MLPA provided an additional explanatory value of 10% to the molecular etiology. However, 10% of the cases of HH still remain unexplained even after a comprehensive genetic work-up. Biochemical findings suggest distinct biochemical profiles between FGF23-dependent and FGF23-independent HH groups.
- 22 November 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 38 (1) , 37-44
Body composition assessment measured via bioelectrical impedance analysis in euthyroid children with newly diagnosed Hashimoto’s thyroiditis
Objectives: The effects of thyroid hormones on body composition are well-known. We aimed to examine the body composition of children with and without Hashimoto’s thyroiditis (HT) by bioelectrical impedance analysis (BIA) while they were still euthyroid. Methods: Between the ages of 5 and 18, 53 girls and 12 boys in each group, 65 children with HT, and 65 healthy children were included in this study. The Tanita MC-780 MA model was used to evaluate body composition parameters. These are fat mass (FM), fat-free mass (FFM), muscle mass (MM), bone mass (BM), total body water (TBW), phase angle, the ratio of muscle mass to fat mass (MFR), basal metabolic rate (BMR), and sarcopenic index (SI). Weight, height, body mass index standard deviation scores (SDSs), and pubertal status were examined. Additionally, TSH, Free-T4, Free-T3, Anti-TPO, Anti-Tg, serum lipid levels, and thyroid volumes were compared. Results: We observed that TBW (27.5 ± 7.5 kg vs. 24.8 ± 6.6 kg; p=0.029) and BMR (1,403 ± 253 kcal vs. 1,324 ± 200 kcal; p=0.049) were higher in the HT group. These differences are due to differences in age and muscle mass in the male group. The FM, FFM, MM, BM, MFR, SI, and phase angle scores did not differ between females with and without HT in euthyroid children by the BIA method. Conclusions: There is no significant change in body composition in euthyroid females with HT at admission.
- 22 November 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 38 (1) , 37-44
Body composition assessment measured via bioelectrical impedance analysis in euthyroid children with newly diagnosed Hashimoto’s thyroiditis
Objectives: The effects of thyroid hormones on body composition are well-known. We aimed to examine the body composition of children with and without Hashimoto’s thyroiditis (HT) by bioelectrical impedance analysis (BIA) while they were still euthyroid. Methods: Between the ages of 5 and 18, 53 girls and 12 boys in each group, 65 children with HT, and 65 healthy children were included in this study. The Tanita MC-780 MA model was used to evaluate body composition parameters. These are fat mass (FM), fat-free mass (FFM), muscle mass (MM), bone mass (BM), total body water (TBW), phase angle, the ratio of muscle mass to fat mass (MFR), basal metabolic rate (BMR), and sarcopenic index (SI). Weight, height, body mass index standard deviation scores (SDSs), and pubertal status were examined. Additionally, TSH, Free-T4, Free-T3, Anti-TPO, Anti-Tg, serum lipid levels, and thyroid volumes were compared. Results: We observed that TBW (27.5 ± 7.5 kg vs. 24.8 ± 6.6 kg; p=0.029) and BMR (1,403 ± 253 kcal vs. 1,324 ± 200 kcal; p=0.049) were higher in the HT group. These differences are due to differences in age and muscle mass in the male group. The FM, FFM, MM, BM, MFR, SI, and phase angle scores did not differ between females with and without HT in euthyroid children by the BIA method. Conclusions: There is no significant change in body composition in euthyroid females with HT at admission.